O
EXAS

Ossiam’s Exact Sciences EXAS Stock Holding History

Ossiam’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,988
Closed -$844K – 648
2024
Q2 		$844K Buy
19,988
+274
+1% +$15.1K 0.02% 384
2024
Q1 		$1.36M Buy
19,714
+172
+0.9% +$10.9K 0.02% 320
2023
Q4 		$1.45M Hold
19,542
– – 0.02% 287
2023
Q3 		$1.33M Buy
19,542
+13,744
+237% +$1.17M 0.02% 295
2023
Q2 		$544K Buy
5,798
+3,202
+123% +$250K 0.01% 419
2023
Q1 		$176K Buy
2,596
+181
+7% +$11.6K ﹤0.01% 501
2022
Q4 		$120K Hold
2,415
– – ﹤0.01% 544
2022
Q3 		$78K Buy
+2,415
New +$99.6K ﹤0.01% 626

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Ossiam's EXAS Position: Q3 2024 in Review

Ossiam sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 19,988 shares — an estimated $844K sold.

Ossiam first reported a position in EXAS in Q3 2022 and held it in 8 quarters. The position peaked at $1.45M in Q4 2023. 598 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Ossiam reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Ossiam sold 19,988 Exact Sciences shares in Q3 2024, an estimated $844K.
  • Ossiam first reported a position in Exact Sciences in Q3 2022 and held it in 8 quarters.
  • Ossiam's Exact Sciences position peaked at $1.45M in Q4 2023.
  • 598 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Ossiam's 13F filing for Q3 2024, filed 13 Nov 2024.